Teri Jones Heiland
Fondateur chez Immunomic Therapeutics, Inc.
Profil
Teri Jones Heiland is the founder of Capital Genomix, Inc., Immunomic Therapeutics, Inc. She previously worked as a Senior Scientist at Kirkegaard & Perry Laboratories, Inc. She holds a doctorate degree from the University of Missouri, which she received in 1993.
Postes actifs de Teri Jones Heiland
| Sociétés | Poste | Début |
|---|---|---|
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Fondateur | - |
Anciens postes connus de Teri Jones Heiland
| Sociétés | Poste | Fin |
|---|---|---|
Kirkegaard & Perry Laboratories, Inc.
 Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Directeur Technique/Scientifique/R&D | - |
Capital Genomix, Inc.
 Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Fondateur | - |
Formation de Teri Jones Heiland
| University of Missouri | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Capital Genomix, Inc.
Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Health Technology |
Kirkegaard & Perry Laboratories, Inc.
Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Process Industries |